2.7. P-gp ATPase assay

KV Kara L. Vine
LB Lisa Belfiore
LJ Luke Jones
JL Julie M. Locke
SW Samantha Wade
EM Elahe Minaei
MR Marie Ranson
ask Ask a question
Favorite

The effect of compounds 1-5 on P-gp ATPase activity was measured using the Pgp-Glo™ assay system. Verapamil, a P-gp substrate and competitive inhibitor for other substrates, was used as a positive control. Sodium orthovanadate (Na3VO4), a selective inhibitor of P-gp ATPase, was used to account for P-gp-independent ATP consumption in the reactions. All compounds and controls were tested at either 40 μM or 200 μM (in 1% DMSO) as per the manufacturer's protocol. Sample luminescence was recorded after 50 min incubation with the ATP detection reagent using a luminometer (POLARstar Omega, BMG Labtech, Ortenberg, Germany). Change in luminescence in relative light units (RLU; RLUNa3VO4–RLUcompound) is inversely proportional to ATP levels, which are negatively correlated with the activity of P-gp ATPase and therefore P-gp-mediated transport.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A